Joint with: Nucleic Acid Therapeutics and Targeted Delivery
Precision Genome Engineering: From Basic Mechanisms to Application
Mar 09–12, 2026 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers:
Jonathan S. Weissman, Cecilia Cotta-Ramusino and Joseph Bondy-Denomy
In Person
On Demand
Mar 09–12, 2026 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers:
Jonathan S. Weissman, Cecilia Cotta-Ramusino and Joseph Bondy-Denomy
Available Formats:
In Person
On Demand
Supported by the Directors' Fund
Available Formats: = In Person = On Demand
Monday, March 9, 2026
Booking Function
Merchandise Options
Registration Options
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Tuesday, March 10, 2026
Breakfast
7:00–8:00 AM
Welcome and Keynote Session (Joint)
8:00–9:00 AM
Katalin Karikó †, BioNTech RNA Pharmaceuticals
Talk Title to be Announced
Talk Title to be Announced
Delivery (Joint)
9:00–11:15 AM
Daniel J. Siegwart †, University of Texas Southwestern Medical Center
New LNP Modalities for Target Lung, Heart and Other Tissues
New LNP Modalities for Target Lung, Heart and Other Tissues
Michael A. Fischbach †, Stanford University
Engineered Viral-Like Particle for Targeted Delivery of Gene Editors
Engineered Viral-Like Particle for Targeted Delivery of Gene Editors
Leah R. Sabin †, Regeneron Pharmaceuticals
Antibody-AAV Targeting: Fundamental Principle Behind Achieving BBB Crossing
Antibody-AAV Targeting: Fundamental Principle Behind Achieving BBB Crossing
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Poster Setup
11:15–1:00 PM
On Own for Lunch
11:15–5:00 PM
Poster Viewing
1:00–10:00 PM
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
New Editing Modality
5:00–7:00 PM
Samuel H. Sternberg †, Columbia University
CRISPR Guided Transposons
CRISPR Guided Transposons
Patrick D. Hsu †, Arc Institute | University of California, Berkeley
Bridge RNA-Directed Programmable Recombination
Bridge RNA-Directed Programmable Recombination
Feng Zhang †, Broad Institute of MIT and Harvard University
Discovery and Characterization of New Genome Editing Tools
Discovery and Characterization of New Genome Editing Tools
Cecilia Cotta-Ramusino, Tessera Therapeutics
Discovery and Application of New Gene Editing Modalities to Treat Disease
Discovery and Application of New Gene Editing Modalities to Treat Disease
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, March 11, 2026
Breakfast
7:00–8:00 AM
Intersection of Gene Editing and Machine Learning
8:00–11:00 AM
Hyongbum Henry Kim †, Yonsei University College of Medicine
Experimental and Machine Learning Approaches to Create New Genome Editing Tools
Experimental and Machine Learning Approaches to Create New Genome Editing Tools
Jonathan S. Weissman, Whitehead Institute, HHMI, and MIT
In vivo Multiple Modal Information-Rich CRISPR Screens
In vivo Multiple Modal Information-Rich CRISPR Screens
Daphne Koller †, insitro
Applications of CRISPR Screen and Machine Learning for Drug Discovery
Applications of CRISPR Screen and Machine Learning for Drug Discovery
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable (Joint)
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Understanding and Applying CRISPR Tools
5:00–7:00 PM
Jennifer A. Doudna †, HHMI/University of California, Berkeley
Mechanism of CRISPR
Mechanism of CRISPR
Randall J. Platt †, ETH Zurich
Functional Genomic Approaches
Functional Genomic Approaches
Tuuli Lappalainen †, KTH Royal Institute of Technology
Genetic Approaches to Discover New Therapeutic Targets
Genetic Approaches to Discover New Therapeutic Targets
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Thursday, March 12, 2026
Breakfast
7:00–8:00 AM
Therapeutic Application
8:00–11:00 AM
Jennifer Gori †, Prime Medicine, Inc.
Application of Prime Editing to Treat Disease
Application of Prime Editing to Treat Disease
Haihua Chu †, Beam Therapeutics
Base Editing to Treat SCT
Base Editing to Treat SCT
Laura Sepp-Lorenzino †, Intellia Therapeutics
TTR Therapies
TTR Therapies
Luigi M. Naldini †, San Raffaele Telethon Institute for Gene Therapy
Gene Editing: Therapeutics and Genotoxicity
Gene Editing: Therapeutics and Genotoxicity
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
CRISPR Biology
5:00–6:45 PM
Joseph Bondy-Denomy, University of California, San Francisco
AntiCRISPR Phage Defense Against CRISPR Systems
AntiCRISPR Phage Defense Against CRISPR Systems
Rafael Pinilla Redondo †, University of Copenhagen
RNA Based Anti-CRISPRs and Type IV CRISPR “Natural Crispri” System
RNA Based Anti-CRISPRs and Type IV CRISPR “Natural Crispri” System
Elizabeth Kellogg †, St. Jude Children's Research Hospital
Mechanism of Programmable Transposases
Mechanism of Programmable Transposases
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions
6:45–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Cash Bar
8:00–11:00 PM
Entertainment
8:00–11:00 PM
Friday, March 13, 2026
Departure
12:00–11:59 PM
Subscribe for Updates